2021
DOI: 10.1182/bloodadvances.2021004267
|View full text |Cite
|
Sign up to set email alerts
|

ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America

Abstract: Background: Venous thromboembolism (VTE) is a common disease in Latin American settings. Implementing international guidelinn Aes in Latimerican settings requires additional considerations. Objective: The purpose of our study was to provide evidence-based guidelines about managing VTE for Latin American patients, clinicians, and decision makers. Methods: We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE)-ADOLOPMENT method to adapt recommendation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 46 publications
0
3
0
2
Order By: Relevance
“…심부정맥 혈전증과 폐동맥색전증은 정맥 혈전색전증의 주 된 형태로, 최근 들어 빠르게 증가하고 있으며, 지역사회와 병 원 내 환자에서 상당한 사망률을 나타낸다 (1)(2)(3). 주된 치료는 항응고요법이며, 목적은 진단 이후 3∼6개월 이내에 가장 높 은 혈전증의 재발, 색전증 등의 합병증 및 사망을 막고자 함이 다.…”
Section: 서 론unclassified
See 1 more Smart Citation
“…심부정맥 혈전증과 폐동맥색전증은 정맥 혈전색전증의 주 된 형태로, 최근 들어 빠르게 증가하고 있으며, 지역사회와 병 원 내 환자에서 상당한 사망률을 나타낸다 (1)(2)(3). 주된 치료는 항응고요법이며, 목적은 진단 이후 3∼6개월 이내에 가장 높 은 혈전증의 재발, 색전증 등의 합병증 및 사망을 막고자 함이 다.…”
Section: 서 론unclassified
“…주된 치료는 항응고요법이며, 목적은 진단 이후 3∼6개월 이내에 가장 높 은 혈전증의 재발, 색전증 등의 합병증 및 사망을 막고자 함이 다. 정맥 혈전색전증으로 진단받고 첫 5∼10일간의 항응고제 사용 후 보다 장기간의 항응고제 유지치료가 필요한데, 여러 연구지침에서 권고하고, 최근 많이 사용되는 direct oral anticoagulants (DOACs)에 대해 정리해 보고자 한다 (2)(3)(4)(5)(6).…”
Section: 서 론unclassified
“…Organizations and individuals in several countries immediately expressed an interest in endorsing and/or adapting the guideline for use in their jurisdictions given the extensive human, financial and technical resources required to create a de novo CPG. However, while guidelines in other chronic disease spaces such as lung cancer, psychosis, and rheumatology [ [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] ] have successfully demonstrated adaptation from one country to another, an adaptation of an obesity CPG had, to our knowledge, never been implemented.…”
Section: Introductionmentioning
confidence: 99%
“…The recommendations included in this document complement the previously published guidelines about management of VTE in adults, and its prevention in surgical and medical patients, as well in long-distance travelers. 4 This manuscript refers to the adaptation of the following ASH guidelines: Diagnosis of VTE, 5 Management of VTE in pregnant women 6 and management of VTE in children. 7…”
Section: Introduction Aim Of These Guidelines and Specific Objectivesmentioning
confidence: 99%
“…The recommendations included in this document complement the previously published guidelines about the management of VTE in adults and its prevention in surgical and medical patients, as well as in long-distance travelers. 4 …”
Section: Introductionmentioning
confidence: 99%